| Year |
Citation |
Score |
| 2020 |
Zhang Y, Sherwin CM, Gonzalez D, Zhang Q, Khurana M, Fisher J, Burckart GJ, Wang Y, Yao LP, Ganley CJ, Wang J. Creatinine-Based Renal Function Assessment in Pediatric Drug Development: An Analysis Using Clinical Data for Renally Eliminated Drugs. Clinical Pharmacology and Therapeutics. PMID 32696977 DOI: 10.1002/Cpt.1991 |
0.331 |
|
| 2020 |
Al-Khouja A, Park K, Anderson DJC, Young C, Wang J, Huang SM, Khurana M, Burckart GJ. Dosing Recommendations for Pediatric Patients With Renal Impairment. Journal of Clinical Pharmacology. PMID 32542790 DOI: 10.1002/Jcph.1676 |
0.339 |
|
| 2020 |
Tanaudommongkon I, Miyagi SJ, Green DJ, Burnham JM, van den Anker JN, Park K, Wu J, McCune SK, Yao L, Burckart GJ. Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012-2018. Clinical Pharmacology and Therapeutics. PMID 32394430 DOI: 10.1002/Cpt.1886 |
0.338 |
|
| 2020 |
Zhang Y, Wang Y, Khurana M, Sachs HC, Zhu H, Burckart GJ, Alexander J, Yao LP, Wang J. Exposure-Response Assessment in Pediatric Drug Development Studies Submitted to the US FDA. Clinical Pharmacology and Therapeutics. PMID 32030741 DOI: 10.1002/Cpt.1809 |
0.32 |
|
| 2019 |
Song YK, Han N, Burckart GJ, Mi Oh J. International Coherence of Pediatric Drug Labeling for Drug Safety: Comparison of Korean MFDS and US FDA Approved Labels. Clinical Pharmacology and Therapeutics. PMID 31544241 DOI: 10.1002/Cpt.1640 |
0.335 |
|
| 2019 |
Cheung KWK, van Groen BD, Burckart GJ, Zhang L, de Wildt SN, Huang SM. Incorporating Ontogeny in Physiologically Based Pharmacokinetic Modeling to Improve Pediatric Drug Development: What We Know About Developmental Changes in Membrane Transporters. Journal of Clinical Pharmacology. 59: S56-S69. PMID 31502692 DOI: 10.1002/Jcph.1489 |
0.352 |
|
| 2019 |
Burckart GJ, van den Anker JN. Pediatric Ontogeny: Moving From Translational Science to Drug Development. Journal of Clinical Pharmacology. 59: S7-S8. PMID 31502690 DOI: 10.1002/Jcph.1481 |
0.323 |
|
| 2019 |
Zhang Y, Mehta N, Muhari-Stark E, Burckart GJ, Anker JVD, Wang J. Pediatric Renal Ontogeny and Applications in Drug Development. Journal of Clinical Pharmacology. 59: S9-S20. PMID 31502684 DOI: 10.1002/Jcph.1490 |
0.312 |
|
| 2019 |
Liu XI, Dallmann A, Wang YM, Green DJ, Burnham JM, Chiang B, Wu P, Sheng M, Lu K, Anker JNVD, Burckart GJ. Monoclonal Antibodies and Fc-Fusion Proteins for Pediatric Use: Dosing, Immunogenicity, and Modeling and Simulation in Data Submitted to the US Food and Drug Administration. Journal of Clinical Pharmacology. PMID 30865317 DOI: 10.1002/Jcph.1406 |
0.327 |
|
| 2018 |
Muhari-Stark E, Burckart GJ. Glomerular Filtration Rate Estimation Formulas for Pediatric and Neonatal Use. The Journal of Pediatric Pharmacology and Therapeutics : Jppt : the Official Journal of Ppag. 23: 424-431. PMID 30697127 DOI: 10.5863/1551-6776-23.6.424 |
0.306 |
|
| 2018 |
Wang J, Kumar SS, Sherwin CM, Ward R, Baer G, Burckart GJ, Wang Y, Yao LP. Renal Clearance in Newborns and Infants: Predictive Performance of Population Based Modeling for Drug Development. Clinical Pharmacology and Therapeutics. PMID 30565653 DOI: 10.1002/Cpt.1332 |
0.318 |
|
| 2018 |
Salerno SN, Burckart GJ, Huang SM, Gonzalez D. Pediatric Drug-Drug Interaction Studies: Barriers and Opportunities. Clinical Pharmacology and Therapeutics. PMID 30362111 DOI: 10.1002/Cpt.1234 |
0.352 |
|
| 2018 |
Green DJ, Sun H, Burnham J, Liu XI, van den Anker J, Temeck J, Yao L, McCune SK, Burckart GJ. Surrogate Endpoints in Pediatric Studies Submitted to the US FDA. Clinical Pharmacology and Therapeutics. PMID 30094815 DOI: 10.1002/Cpt.1117 |
0.356 |
|
| 2018 |
Green DJ, Duong SQ, Burckart GJ, Sissung T, Price DK, Figg WD, Brooks MM, Chinnock R, Canter C, Addonizio L, Bernstein D, Naftel DC, Zeevi A, Kirklin JK, Webber SA, et al. Association Between Thiopurine S-Methyltransferase () Genetic Variants and Infection in Pediatric Heart Transplant Recipients Treated With Azathioprine: A Multi-Institutional Analysis. The Journal of Pediatric Pharmacology and Therapeutics : Jppt : the Official Journal of Ppag. 23: 106-110. PMID 29720911 DOI: 10.5863/1551-6776-23.2.106 |
0.369 |
|
| 2018 |
Green DJ, Zineh I, Burckart GJ. Pediatric Drug Development: Outlook for Science-Based Innovation. Clinical Pharmacology and Therapeutics. PMID 29384202 DOI: 10.1002/Cpt.1001 |
0.36 |
|
| 2018 |
Vaughns JD, Conklin LS, Long Y, Zheng P, Faruque F, Green DJ, van den Anker JN, Burckart GJ. Obesity and Pediatric Drug Development. Journal of Clinical Pharmacology. PMID 29350758 DOI: 10.1002/Jcph.1054 |
0.309 |
|
| 2017 |
Patel SK, Leong R, Zhao H, Barone A, Casey D, Liu Q, Burckart GJ, Reaman G. Pediatric Development of Molecularly Targeted Oncology Drugs. Clinical Pharmacology and Therapeutics. PMID 29226303 DOI: 10.1002/Cpt.942 |
0.321 |
|
| 2017 |
Green DJ, Liu XI, Hua T, Burnham JM, Schuck R, Pacanowski M, Yao L, McCune SK, Burckart GJ, Zineh I. Enrichment Strategies in Pediatric Drug Development: An Analysis of Trials Submitted to the US Food and Drug Administration. Clinical Pharmacology and Therapeutics. PMID 29218740 DOI: 10.1002/Cpt.971 |
0.309 |
|
| 2017 |
Leong R, Zhao H, Reaman G, Liu Q, Wang Y, Stewart CF, Burckart G. Bridging Adult Experience to Pediatrics in Oncology Drug Development. Journal of Clinical Pharmacology. 57: S129-S135. PMID 28921643 DOI: 10.1002/Jcph.910 |
0.354 |
|
| 2017 |
Avant D, Baer G, Moore J, Zheng P, Sorbello A, Ariagno R, Yao L, Burckart GJ, Wang J. Neonatal Safety Information Reported to the FDA During Drug Development Studies. Therapeutic Innovation & Regulatory Science. 2017: 1-9. PMID 28804696 DOI: 10.1177/2168479017716713 |
0.335 |
|
| 2016 |
Green DJ, Brooks MM, Burckart GJ, Chinnock RE, Canter C, Addonizio LJ, Bernstein D, Kirklin JK, Naftel DC, Girnita DM, Zeevi A, Webber SA. The Influence of Race and Common Genetic Variations on Outcomes After Pediatric Heart Transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 27931092 DOI: 10.1111/Ajt.14153 |
0.36 |
|
| 2016 |
Zimmerman K, Putera M, Hornik CP, Brian Smith P, Benjamin DK, Mulugeta Y, Burckart GJ, Cohen-Wolkowiez M, Gonzalez D. Exposure Matching of Pediatric Anti-infective Drugs: Review of Drugs Submitted to the Food and Drug Administration for Pediatric Approval. Clinical Therapeutics. PMID 27364807 DOI: 10.1016/J.Clinthera.2016.06.003 |
0.324 |
|
| 2016 |
Mulugeta Y, Barrett JS, Nelson R, Eshete AT, Mushtaq A, Yao L, Glasgow N, Mulberg AE, Gonzalez D, Green D, Florian J, Krudys K, Seo S, Kim I, Chilukuri D, ... Burckart GJ, et al. Exposure Matching for Extrapolation of Efficacy in Pediatric Drug Development. Journal of Clinical Pharmacology. PMID 27040726 DOI: 10.1002/Jcph.744 |
0.319 |
|
| 2015 |
Green DJ, Mummaneni P, Kim IW, Oh JM, Pacanowski M, Burckart GJ. Pharmacogenomic Information in FDA-Approved Drug Labels: Application to Pediatric Patients. Clinical Pharmacology and Therapeutics. PMID 26693845 DOI: 10.1002/Cpt.330 |
0.334 |
|
| 2015 |
Bai JP, Burckart GJ, Mulberg AE. Literature Review of Gastrointestinal Physiology in the Elderly, in Pediatric Patients, and in Patients with Gastrointestinal Diseases. Journal of Pharmaceutical Sciences. PMID 26539698 DOI: 10.1002/Jps.24696 |
0.325 |
|
| 2015 |
Wang J, Avant D, Green D, Seo S, Fisher J, Mulberg AE, McCune SK, Burckart GJ. A survey of neonatal pharmacokinetic and pharmacodynamic studies in pediatric drug development. Clinical Pharmacology and Therapeutics. PMID 25975723 DOI: 10.1002/Cpt.149 |
0.367 |
|
| 2015 |
Wang J, Edginton AN, Avant D, Burckart GJ. Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modeling. Journal of Clinical Pharmacology. PMID 25907280 DOI: 10.1002/Jcph.524 |
0.303 |
|
| 2015 |
Wang J, Edginton AN, Burckart G. Using modeling and simulation for neonatal drug development Neoreviews. 16: e648-e652. DOI: 10.1542/Neo.16-11-E648 |
0.311 |
|
| 2014 |
Momper JD, Karesh A, Green DJ, Hirsch M, Khurana M, Lee J, Kim MJ, Mulugeta Y, Sachs HC, Yao L, Burckart GJ. Drug development for pediatric neurogenic bladder dysfunction: dosing, endpoints, and study design. Journal of Clinical Pharmacology. 54: 1239-46. PMID 24922179 DOI: 10.1002/Jcph.345 |
0.353 |
|
| 2014 |
Burckart GJ, Figg WD, Brooks MM, Green DJ, Troutman SM, Ferrell R, Chinnock R, Canter C, Addonizio L, Bernstein D, Kirklin JK, Naftel D, Price DK, Sissung TM, Girnita DM, et al. Multi-institutional Study of Outcomes After Pediatric Heart Transplantation: Candidate Gene Polymorphism Analysis of ABCC2. The Journal of Pediatric Pharmacology and Therapeutics : Jppt : the Official Journal of Ppag. 19: 16-24. PMID 24782687 DOI: 10.5863/1551-6776-19.1.16 |
0.356 |
|
| 2013 |
Lala M, Burckart GJ, Takao CM, Pravica V, Momper JD, Gobburu JV. Genetics-based pediatric warfarin dosage regimen derived using pharmacometric bridging. The Journal of Pediatric Pharmacology and Therapeutics : Jppt : the Official Journal of Ppag. 18: 209-19. PMID 24052784 DOI: 10.5863/1551-6776-18.3.209 |
0.349 |
|
| 2013 |
Momper JD, Mulugeta Y, Green DJ, Karesh A, Krudys KM, Sachs HC, Yao LP, Burckart GJ. Adolescent dosing and labeling since the Food and Drug Administration Amendments Act of 2007. Jama Pediatrics. 167: 926-32. PMID 23921678 DOI: 10.1001/Jamapediatrics.2013.465 |
0.319 |
|
| 2013 |
Chang Y, Burckart GJ, Lesko LJ, Dowling TC. Evaluation of hepatic impairment dosing recommendations in FDA-approved product labels. Journal of Clinical Pharmacology. 53: 962-6. PMID 23832278 DOI: 10.1002/Jcph.128 |
0.306 |
|
| 2012 |
Leong R, Vieira MLT, Zhao P, Mulugeta Y, Lee CS, Huang SM, Burckart GJ. Regulatory experience with physiologically based pharmacokinetic modeling for pediatric drug trials Clinical Pharmacology and Therapeutics. 91: 926-931. PMID 22472993 DOI: 10.1038/Clpt.2012.19 |
0.354 |
|
| 2012 |
Kim IW, Noh H, Ji E, Han N, Hong SH, Ha J, Burckart GJ, Oh JM. Identification of factors affecting tacrolimus level and 5-year clinical outcome in kidney transplant patients. Basic & Clinical Pharmacology & Toxicology. 111: 217-23. PMID 22469198 DOI: 10.1111/J.1742-7843.2012.00892.X |
0.385 |
|
| 2011 |
Bashaw ED, Huang SM, Coté TR, Pariser AR, Garnett CE, Burckart G, Zhang L, Men AY, Le CD, Charlab R, Gobburu JV, Lesko LJ. Clinical pharmacology as a cornerstone of orphan drug development. Nature Reviews. Drug Discovery. 10: 795-6. PMID 22037026 DOI: 10.1038/Nrd3595 |
0.335 |
|
| 2011 |
Dunne J, Rodriguez WJ, Murphy MD, Beasley BN, Burckart GJ, Filie JD, Lewis LL, Sachs HC, Sheridan PH, Starke P, Yao LP. Extrapolation of adult data and other data in pediatric drug-development programs. Pediatrics. 128: e1242-9. PMID 22025597 DOI: 10.1542/Peds.2010-3487 |
0.322 |
|
| 2011 |
Bai JP, Bell R, Buckman S, Burckart GJ, Eichler HG, Fang KC, Goodsaid FM, Jusko WJ, Lesko LL, Meibohm B, Patterson SD, Puig O, Smerage JB, Snider BJ, Wagner JA, et al. Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker Workshop. The Aaps Journal. 13: 274-83. PMID 21448748 DOI: 10.1208/S12248-011-9265-X |
0.305 |
|
| 2010 |
Dowling TC, Matzke GR, Murphy JE, Burckart GJ. Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches. Pharmacotherapy. 30: 776-86. PMID 20653353 DOI: 10.1592/Phco.30.8.776 |
0.338 |
|
| 2010 |
Burckart GJ, Amur S. Update on the clinical pharmacogenomics of organ transplantation. Pharmacogenomics. 11: 227-36. PMID 20136361 DOI: 10.2217/Pgs.09.177 |
0.416 |
|
| 2009 |
Girnita DM, Webber SA, Brooks MM, Ferrell R, Girnita AL, Burckart GJ, Chinnock R, Canter C, Addonizio L, Bernstein D, Kirklin JK, Naftel D, Zeevi A. Genotypic variation and phenotypic characterization of granzyme B gene polymorphisms. Transplantation. 87: 1801-6. PMID 19543056 DOI: 10.1097/Tp.0B013E3181A755A4 |
0.314 |
|
| 2009 |
Chen Y, Burckart GJ, Shah T, Pravica V, Hutchinson IV. A novel method for monitoring glucocorticoid-induced changes of the glucocorticoid receptor in kidney transplant recipients. Transplant Immunology. 20: 249-52. PMID 19162184 DOI: 10.1016/J.Trim.2008.12.003 |
0.36 |
|
| 2008 |
Burckart GJ. Pharmacogenomics: the key to improved drug therapy in transplant patients. Clinics in Laboratory Medicine. 28: 411-22, vi. PMID 19028260 DOI: 10.1016/J.Cll.2008.09.004 |
0.414 |
|
| 2008 |
Frueh FW, Amur S, Mummaneni P, Epstein RS, Aubert RE, DeLuca TM, Verbrugge RR, Burckart GJ, Lesko LJ. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use. Pharmacotherapy. 28: 992-8. PMID 18657016 DOI: 10.1592/Phco.28.8.992 |
0.334 |
|
| 2008 |
Girnita DM, Brooks MM, Webber SA, Burckart GJ, Ferrell R, Zdanowicz G, DeCroo S, Smith L, Chinnock R, Canter C, Addonizio L, Bernstein D, Kirklin JK, Ranganathan S, Naftel D, et al. Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: a multi-institutional study. Transplantation. 85: 1632-9. PMID 18551071 DOI: 10.1097/Tp.0B013E3181722Edc |
0.357 |
|
| 2008 |
Huang SM, Strong JM, Zhang L, Reynolds KS, Nallani S, Temple R, Abraham S, Habet SA, Baweja RK, Burckart GJ, Chung S, Colangelo P, Frucht D, Green MD, Hepp P, et al. New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process. Journal of Clinical Pharmacology. 48: 662-70. PMID 18378963 DOI: 10.1177/0091270007312153 |
0.328 |
|
| 2008 |
Burckart GJ, Amur S, Goodsaid FM, Lesko LJ, Frueh FW, Huang SM, Cavaille-Coll MW. Qualification of biomarkers for drug development in organ transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 8: 267-70. PMID 18093264 DOI: 10.1111/J.1600-6143.2007.02063.X |
0.421 |
|
| 2008 |
Wang J, Yang JW, Zeevi A, Webber SA, Girnita DM, Selby R, Fu J, Shah T, Pravica V, Hutchinson IV, Burckart GJ. IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients Clinical Pharmacology and Therapeutics. 83: 711-717. PMID 17851563 DOI: 10.1038/Sj.Clpt.6100347 |
0.384 |
|
| 2007 |
Burckart GJ. Transplant pharmacy: 30 years of improving patient care. The Annals of Pharmacotherapy. 41: 1261-3. PMID 17595304 DOI: 10.1345/Aph.1K239 |
0.329 |
|
| 2007 |
Wang J, Zeevi A, Webber S, Girnita DM, Addonizio L, Selby R, Hutchinson IV, Burckart GJ. A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity. Pharmacogenetics and Genomics. 17: 283-90. PMID 17496727 DOI: 10.1097/Fpc.0B013E328012B8Cf |
0.304 |
|
| 2006 |
Girnita DM, Webber SA, Ferrell R, Burckart GJ, Brooks MM, McDade KK, Chinnock R, Canter C, Addonizio L, Bernstein D, Kirklin JK, Girnita AL, Zeevi A. Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups of pediatric heart transplant patients. Transplantation. 82: 1774-80. PMID 17198275 DOI: 10.1097/01.Tp.0000250656.33731.08 |
0.31 |
|
| 2006 |
Burckart GJ. Ciclosporin aerosol in lung transplantation. Expert Opinion On Investigational Drugs. 15: 981-6. PMID 16859398 DOI: 10.1517/13543784.15.8.981 |
0.411 |
|
| 2006 |
Burckart GJ, Hutchinson IV, Zeevi A. Pharmacogenomics and lung transplantation: Clinical implications Pharmacogenomics Journal. 6: 301-310. PMID 16520825 DOI: 10.1038/Sj.Tpj.6500376 |
0.429 |
|
| 2006 |
Wang J, Zeevi A, McCurry K, Schuetz E, Zheng H, Iacono A, McDade K, Zaldonis D, Webber S, Watanabe RM, Burckart GJ. Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 *3/*3 non-expressors. Transplant Immunology. 15: 235-40. PMID 16431292 DOI: 10.1016/J.Trim.2005.08.001 |
0.372 |
|
| 2006 |
Burckart GJ, Liu XI. Pharmacogenetics in transplant patients: can it predict pharmacokinetics and pharmacodynamics? Therapeutic Drug Monitoring. 28: 23-30. PMID 16418689 DOI: 10.1097/01.Ftd.0000194502.85763.Bc |
0.397 |
|
| 2006 |
Iacono AT, Johnson BA, Grgurich WF, Youssef JG, Corcoran TE, Seiler DA, Dauber JH, Smaldone GC, Zeevi A, Yousem SA, Fung JJ, Burckart GJ, McCurry KR, Griffith BP. A randomized trial of inhaled cyclosporine in lung-transplant recipients. The New England Journal of Medicine. 354: 141-50. PMID 16407509 DOI: 10.1056/Nejmoa043204 |
0.374 |
|
| 2006 |
Girnita D, Webber S, Ferrell R, Burckart G, Brooks M, Chinnock R, Canter C, Addonizio L, Bernstein D, Kirklin J, Zeevi A. Disparate genetic polymorphism among ethnic groups in pediatric heart transplantation Human Immunology. 67: S118. DOI: 10.1016/J.Humimm.2006.08.179 |
0.335 |
|
| 2005 |
Liu S, Frye RF, Branch RA, Venkataramanan R, Fung JJ, Burckart GJ. Effect of age and postoperative time on cytochrome p450 enzyme activity following liver transplantation. Journal of Clinical Pharmacology. 45: 666-73. PMID 15901748 DOI: 10.1177/0091270005276202 |
0.352 |
|
| 2005 |
Zheng HX, Zeevi A, McCurry K, Schuetz E, Webber S, Ristich J, Zhang J, Iacono A, Dauber J, McDade K, Zaldonis D, Lamba J, Burckart GJ. The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients. Transplant Immunology. 14: 37-42. PMID 15814280 DOI: 10.1016/J.Trim.2004.11.001 |
0.408 |
|
| 2005 |
Zheng H, Schuetz E, Zeevi A, Zhang J, McCurry K, Webber S, Iacono A, Lamba J, Burckart GJ. Sequential analysis of tacrolimus dosing in adult lung transplant patients with ABCB1 haplotypes. Journal of Clinical Pharmacology. 45: 404-10. PMID 15778421 DOI: 10.1177/0091270005274507 |
0.412 |
|
| 2005 |
Girnita AL, Duquesnoy R, Yousem SA, Iacono AT, Corcoran TE, Buzoianu M, Johnson B, Spichty KJ, Dauber JH, Burckart G, Griffith BP, McCurry KR, Zeevi A. HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 5: 131-8. PMID 15636621 DOI: 10.1111/J.1600-6143.2004.00650.X |
0.305 |
|
| 2005 |
Pisupati J, Jain A, Burckart G, Hamad I, Zuckerman S, Fung J, Venkataramanan R. Intraindividual and interindividual variations in the pharmacokinetics of mycophenolic acid in liver transplant patients. Journal of Clinical Pharmacology. 45: 34-41. PMID 15601803 DOI: 10.1177/0091270004270145 |
0.306 |
|
| 2005 |
Iacono AT, Capra WB, Shrewsbury SB, Johnson BA, Grgurich WF, Corcoran TE, Youssef JG, Smith-Seiler DA, Smaldone GC, Zeevi A, Yousem SA, Fung JJ, Dauber JH, Burckart GJ, Griffith B, et al. Long-term follow up of a double-blind, randomized, placebo-controlled trial of Cyclosporine Inhalation Solution (CyIS) in lung transplant recipients Journal of Heart and Lung Transplantation. 24. DOI: 10.1016/J.Healun.2004.11.146 |
0.329 |
|
| 2005 |
LIU S, FRYE R, BRANCH R, VENKATARAMANAN R, FUNG J, BURCKART G. Changes in CYP450 enzyme activity over time following liver transplantation Clinical Pharmacology & Therapeutics. 77: P34-P34. DOI: 10.1016/J.Clpt.2004.12.024 |
0.321 |
|
| 2004 |
Zheng HX, Webber SA, Zeevi A, Schuetz E, Zhang J, Lamba J, Boyle GJ, Wilson JW, Burckart GJ. The impact of pharmacogenomic factors on steroid dependency in pediatric heart transplant patients using logistic regression analysis. Pediatric Transplantation. 8: 551-7. PMID 15598322 DOI: 10.1111/J.1399-3046.2004.00223.X |
0.417 |
|
| 2004 |
Cho EK, Han DJ, Kim SC, Burckart GJ, Venkataramanan R, Oh JM. Pharmacokinetic study of mycophenolic acid in Korean kidney transplant patients. Journal of Clinical Pharmacology. 44: 743-50. PMID 15199079 DOI: 10.1177/0091270004266634 |
0.386 |
|
| 2004 |
Zheng HX, Burckart GJ, McCurry K, Webber S, Ristich J, Iacono A, Dauber J, McDade K, Grgurich W, Zaldonis D, Pillage G, Griffith BP, Zeevi A. Interleukin-10 production genotype protects against acute persistent rejection after lung transplantation. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 23: 541-6. PMID 15135368 DOI: 10.1016/S1053-2498(03)00303-6 |
0.321 |
|
| 2004 |
Corcoran TE, Smaldone GC, Dauber JH, Smith DA, McCurry KR, Burckart GJ, Zeevi A, Griffith BP, Iacono AT. Preservation of post-transplant lung function with aerosol cyclosporin European Respiratory Journal. 23: 378-383. PMID 15065825 DOI: 10.1183/09031936.04.00059204 |
0.378 |
|
| 2004 |
Zheng H, Zeevi A, Schuetz E, Lamba J, McCurry K, Griffith BP, Webber S, Ristich J, Dauber J, Iacono A, Grgurich W, Zaldonis D, McDade K, Zhang J, Burckart GJ. Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism. Journal of Clinical Pharmacology. 44: 135-40. PMID 14747421 DOI: 10.1177/0091270003262108 |
0.416 |
|
| 2004 |
Iacono AT, Johnson BA, Corcoran TE, Smith DA, Grgurich WF, Dauber JH, McCurry KR, Zeevi A, Burckart GJ, Youssef JG, Vensak JL, Smaldone GC, Fung JJ, Griffith BP. A randomized trial of early administration of inhaled cyclosporine in lung transplant recipients Journal of Heart and Lung Transplantation. 23. DOI: 10.1016/J.Healun.2003.11.395 |
0.361 |
|
| 2003 |
Carcillo JA, Doughty L, Kofos D, Frye RF, Kaplan SS, Sasser H, Burckart GJ. Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure. Intensive Care Medicine. 29: 980-4. PMID 12698250 DOI: 10.1007/S00134-003-1758-3 |
0.316 |
|
| 2003 |
Zheng H, Webber S, Zeevi A, Schuetz E, Zhang J, Bowman P, Boyle G, Law Y, Miller S, Lamba J, Burckart GJ. Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 3: 477-83. PMID 12694072 DOI: 10.1034/J.1600-6143.2003.00077.X |
0.407 |
|
| 2003 |
Donnenberg VS, Burckart GJ, Donnenberg AD. P-glycoprotein (P-gp) function in T cells: Implications for organ transplantation Clinical and Applied Immunology Reviews. 4: 15-30. DOI: 10.1016/S1529-1049(03)00004-7 |
0.307 |
|
| 2003 |
Zheng HX, Webber S, Zeevi A, Schuetz E, Zhang J, Bowman P, Lamba J, Burckart GJ. The impact of pharmacogenomic factors on steroid weaning in pediatric heart transplant patients using logistic regression analysis Journal of Heart and Lung Transplantation. 22. DOI: 10.1016/S1053-2498(02)00904-X |
0.397 |
|
| 2003 |
Zheng HX, Burckart GJ, McCurry K, Webber S, Zaldonis D, Ristich J, Iacono A, Dauber J, Grgurich W, McDade K, Zeevi A. IL-10 high genotype is protective against acute persistent rejection after lung transplantation Journal of Heart and Lung Transplantation. 22. DOI: 10.1016/S1053-2498(02)00688-5 |
0.325 |
|
| 2003 |
Corcoran TE, Smaldone GC, Dauber JH, Smith DA, McCurry KR, Burckart GJ, Griffith BP, Grgurich WF, Iacono AT. Aerosol cyclosporine provides dose dependent improvement in lung function after lung transplantation Journal of Heart and Lung Transplantation. 22. DOI: 10.1016/S1053-2498(02)00687-3 |
0.326 |
|
| 2003 |
Zheng H, Zeevi A, McCurry K, Schuetz E, Webber S, Ristich J, Zhang J, Iacono A, Dauber J, McDade K, Zaldonis D, Lamba J, Burckart G. MDR1 EXON26 genotype predicts treatment-resistant rejection in lung transplant patients as assessed by logistic regression analysis Human Immunology. 64. DOI: 10.1016/J.Humimm.2003.08.073 |
0.342 |
|
| 2002 |
Zheng H, Webber S, Zeevi A, Schuetz E, Zhang J, Lamba J, Bowman P, Burckart GJ. The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients. Human Immunology. 63: 765-70. PMID 12175731 DOI: 10.1016/S0198-8859(02)00426-3 |
0.346 |
|
| 2002 |
Agarwala S, Culligan E, Jain A, McCauley J, Shapiro R, Chakrabarti P, Burckart G, Venkataramanan R. Evaluation of renal function in transplant patients on tacrolimus therapy. Journal of Clinical Pharmacology. 42: 798-805. PMID 12092747 DOI: 10.1177/009127002401102632 |
0.408 |
|
| 2002 |
Zheng HX, Webber S, Schuetz E, Zeevi A, Lamba J, Zhang J, Bowman P, Burckart G. Cytochrome P4503A5 and TNF-a genotypes are associated with tacrolimus dosing in pediatric heart transplant patients Human Immunology. 63. DOI: 10.1016/S0198-8859(02)00494-9 |
0.377 |
|
| 2001 |
Zeevi A, Pavlakis M, Spichty K, Chang S, Iacono A, Dauber J, Burckart G, McCurry K, Keenan R, Grgurich W, Griffith B. Prediction of rejection in lung transplantation. Transplantation Proceedings. 33: 291-2. PMID 11266823 DOI: 10.1016/S0041-1345(00)02013-3 |
0.342 |
|
| 2000 |
Mitruka SN, Won A, McCurry KR, Zeevi A, McKaveney T, Venkataramanan R, Iacono A, Griffith BP, Burckart GJ. In the lung aerosol cyclosporine provides a regional concentration advantage over intramuscular cyclosporine Journal of Heart and Lung Transplantation. 19: 969-975. PMID 11044692 DOI: 10.1016/S1053-2498(00)00176-5 |
0.348 |
|
| 2000 |
Sindhi R, LaVia MF, Paulling E, McMichael J, Burckart G, Shaw S, Sindhi LA, Livingston R, Sehgal S, Jaffe J. Stimulated response of peripheral lymphocytes may distinguish cyclosporine effect in renal transplant recipients receiving a cyclosporine+rapamycin regimen. Transplantation. 69: 432-6. PMID 10706056 DOI: 10.1097/00007890-200002150-00022 |
0.373 |
|
| 2000 |
Vilchez R, McCurry K, Yalamanchilli H, Burckart G, Iacono A, Zeevi A, Keenan R, Griffith B, Kusne S. ASSOCIATION BETWEEN PARAINFLUENZA VIRUS INFECTION AND ACTIVE BROCHIOLITIS OBLITERANS IN LUNG TRANSPLANT RECIPIENTS.: Abstract# 476 Poster Board #-Session: P116-II Transplantation. 69. DOI: 10.1097/00007890-200004271-00476 |
0.325 |
|
| 1999 |
Agarwala S, Ou J, Subbotin V, Zuckermann S, Randhawa P, Burckart G, Venkataramanan R. Co-administration of co-trimoxazole does not augment tacrolimus-induced impairment in kidney function in rats. Renal Failure. 21: 635-45. PMID 10586426 DOI: 10.3109/08860229909094157 |
0.31 |
|
| 1999 |
Lo A, Burckart GJ. P-glycoprotein and drug therapy in organ transplantation Journal of Clinical Pharmacology. 39: 995-1005. PMID 10516933 DOI: 10.1177/00912709922011755 |
0.344 |
|
| 1999 |
Burckart G, Frye R, Branch R, Venkataramanan R, McKaveney T, Hammond R, Rosenberg C, Fung J, Jain A. DRUG METABOLISM IN OLDER OLTx PATIENTS: EFFECTS OF DONOR AND RECIPIENT AGE. Transplantation. 67: S145. DOI: 10.1097/00007890-199904150-00582 |
0.363 |
|
| 1998 |
Burckart GJ, Frye RF, Kelly P, Branch RA, Jain A, Fung JJ, Starzl TE, Venkataramanan R. Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation. Clinical Pharmacology and Therapeutics. 63: 296-302. PMID 9542473 DOI: 10.1016/S0009-9236(98)90161-8 |
0.362 |
|
| 1998 |
Mitruka SN, Pham SM, Zeevi A, Li S, Cai J, Burckart GJ, Yousem SA, Keenan RJ, Griffith BP. Aerosol cyclosporine prevents acute allograft rejection in experimental lung transplantation. The Journal of Thoracic and Cardiovascular Surgery. 115: 28-36; discussion 36. PMID 9451042 DOI: 10.1016/S0022-5223(98)70439-8 |
0.383 |
|
| 1997 |
Iacono AT, Smaldone GC, Keenan RJ, Diot P, Dauber JH, Zeevi A, Burckart GJ, Griffith BP. Dose-related reversal of acute lung rejection by aerosolized cyclosporine American Journal of Respiratory and Critical Care Medicine. 155: 1690-1698. PMID 9154878 DOI: 10.1164/Ajrccm.155.5.9154878 |
0.321 |
|
| 1997 |
Keenan RJ, Iacono A, Dauber JH, Zeevi A, Yousem SA, Ohori NP, Burckart GJ, Kawai A, Smaldone GC, Griffith BP, Shumway SJ. Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients Journal of Thoracic and Cardiovascular Surgery. 113: 335-341. PMID 9040628 DOI: 10.1016/S0022-5223(97)70331-3 |
0.344 |
|
| 1997 |
Kofos D, Frye R, Burckart G, Reyes J, Carcillo J. Drug Metabolism In Pediatric Liver Transplantation 199 Pediatric Research. 41: 36-36. DOI: 10.1203/00006450-199704001-00219 |
0.337 |
|
| 1996 |
Wong HR, Carcillo JA, Burckart G, Kaplan SS. Nitric oxide production in critically ill patients. Archives of Disease in Childhood. 74: 482-489. PMID 8758122 DOI: 10.1136/Adc.74.6.482 |
0.33 |
|
| 1996 |
Mattsson P, Zeevi A, Cai J, Yousem SA, Hoffman R, Nalesnik M, Burckart GJ, Geller D, Griffith BP. Effect of aminoguanidine and cyclosporine on lung allograft rejection Annals of Thoracic Surgery. 62: 207-212. PMID 8678644 DOI: 10.1016/0003-4975(96)00296-2 |
0.353 |
|
| 1996 |
Iacono AT, Keenan RJ, Duncan SR, Smaldone GC, Dauber JH, Paradis IL, Ohori NP, Grgurich WF, Burckart GJ, Zeevi A, Delgado E, O'riordan TG, Zendarsky MM, Yousem SA, Griffith BP. Aerosolized cyclosporine in lung recipients with refractory chronic rejection American Journal of Respiratory and Critical Care Medicine. 153: 1451-1455. PMID 8616581 DOI: 10.1164/Ajrccm.153.4.8616581 |
0.383 |
|
| 1996 |
Kelly P, Frye R, Burckart G, Lever J, Venkataramanan R, Fung J, Malzke G, Branch R. Differential CYP450 Isozyme Activity Following Orthotopic Liver Transplantation (OLTx) Clinical Pharmacology & Therapeutics. 59: 136-136. DOI: 10.1038/Sj.Clpt.1996.42 |
0.332 |
|
| 1995 |
Venkataramanan R, Swaminathan A, Prasad T, Jain A, Zuckerman S, Warty V, McMichael J, Lever J, Burckart G, Starzl T. Clinical pharmacokinetics of tacrolimus. Clinical Pharmacokinetics. 29: 404-30. PMID 8787947 DOI: 10.2165/00003088-199529060-00003 |
0.361 |
|
| 1995 |
Kelly PA, Burckart GJ, Venkataramanan R. Tacrolimus: a new immuosuppressive agent American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 52: 1521-1535. PMID 7552894 DOI: 10.1093/Ajhp/52.14.1521 |
0.432 |
|
| 1994 |
Dimand RJ, Burckart G, Concepcion W, Hall RJ, Bishop AL, Borland L, Starzl TE. Continuous Infusion Ranitidine in Postoperative Pediatric Liver Transplant Patients: Effects on Intragastric pH, Gastrointestinal Bleeding and Metabolic Alkalosis. American Journal of Therapeutics. 1: 281-286. PMID 11835101 DOI: 10.1097/00045391-199412000-00007 |
0.307 |
|
| 1994 |
Duncan SR, Grgurich WF, Iacono AT, Burckart GJ, Yousem SA, Paradis IL, Williams PA, Johnson BA, Griffith BP. A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation American Journal of Respiratory and Critical Care Medicine. 150: 146-152. PMID 8025741 DOI: 10.1164/Ajrccm.150.1.8025741 |
0.353 |
|
| 1993 |
Aeba R, Stout JE, Francalancia NA, Keenan RJ, Duncan AJ, Yousem SA, Burckart GJ, Yu VL, Griffith BP. Aspects of lung transplantation that contribute to increased severity of pneumonia: An experimental study Journal of Thoracic and Cardiovascular Surgery. 106: 449-457. PMID 8361186 DOI: 10.1016/S0022-5223(19)34078-4 |
0.376 |
|
| 1992 |
Keenan RJ, Duncan AJ, Yousem SA, Zenati M, Schaper M, Dowling RD, Alarie Y, Burckart GJ, Griffith BP. Improved immunosuppression with aerosolized cyclosporine in experimental pulmonary transplantation Transplantation. 53: 20-25. PMID 1733067 DOI: 10.1097/00007890-199201000-00003 |
0.374 |
|
| 1992 |
O'riordan TG, Duncan SR, Burckart GJ, Griffith BP, Smaldone GC. Production of an Aerosol of Cyclosporine as a Prelude to Clinical Studies Journal of Aerosol Medicine-Deposition Clearance and Effects in the Lung. 5: 171-177. DOI: 10.1089/Jam.1992.5.171 |
0.306 |
|
| 1991 |
Toth A, Abdallah HY, Venkataramanan R, Teperman L, Halsf G, Rabinovitch M, Burckart GJ, Starzl TE. Pharmacokinetics of ceftriaxone in liver-transplant recipients Journal of Clinical Pharmacology. 31: 722-728. PMID 1880231 DOI: 10.1002/J.1552-4604.1991.Tb03767.X |
0.338 |
|
| 1991 |
Zenati M, Casarotto D, Duncan AJ, Griffith BP, Burckart GJ, Schaper M, Yousem SA. Immunosuppression with aerosolized cyclosporine for prevention of lung rejection in a rat model European Journal of Cardio-Thoracic Surgery. 5: 266-271. PMID 1859667 DOI: 10.1016/1010-7940(91)90175-J |
0.349 |
|
| 1989 |
Lawless S, Burckart G, Diven W, Thompson A, Siewers R. Amrinone in neonates and infants after cardiac surgery. Critical Care Medicine. 17: 751-754. PMID 2752768 DOI: 10.1097/00003246-198908000-00006 |
0.303 |
|
| 1989 |
Venkataramanan R, Habucky K, Burckart GJ, Ptachcinski RJ. Clinical Pharmacokinetics in Organ Transplant Patients Clinical Pharmacokinetics. 16: 134-161. PMID 2656047 DOI: 10.2165/00003088-198916030-00002 |
0.45 |
|
| 1988 |
Lawless S, Burckart G, Diven W, Thompson A, Siewers R. Amrinone pharmacokinetics in neonates and infants. The Journal of Clinical Pharmacology. 28: 283-284. PMID 3360974 DOI: 10.1002/J.1552-4604.1988.Tb03145.X |
0.328 |
|
| 1988 |
Venkataramanan R, Koneru B, Paul Wang CC, Burckart GJ, Caritis SN, Starzl TE. Cyclosporine and its metabolites in mother and baby Transplantation. 46: 468-469. PMID 3047940 DOI: 10.1097/00007890-198809000-00032 |
0.356 |
|
| 1988 |
Huang ML, Venkataramanan R, Burckart GJ, Ptachcinski RJ, Van Thiel DH, Starzl TE. Drug-binding proteins in liver transplant patients Journal of Clinical Pharmacology. 28: 505-506. PMID 3047175 DOI: 10.1002/J.1552-4604.1988.Tb03167.X |
0.372 |
|
| 1988 |
Mehta MU, Venkataramanan R, Burckart GJ, Ptachcinski RJ, Delamos B, Stachak S, Van Thiel DH, Iwatsuki S, Starzl TE. Effect of bile on cyclosporin absorption in liver transplant patients British Journal of Clinical Pharmacology. 25: 579-584. PMID 3044424 DOI: 10.1111/J.1365-2125.1988.Tb03348.X |
0.353 |
|
| 1988 |
Zeevi A, Venkataramanan R, Burckart G, Wang CP, Murase N, Van Thiel DH, Starzl TE, Makowka L, Duquesnoy RJ. Sensitivity of activated human lymphocytes to cyclosporine and its metabolites. Human Immunology. 21: 143-53. PMID 2966788 DOI: 10.1016/0198-8859(88)90089-4 |
0.342 |
|
| 1987 |
Ptachcinski RJ, Venkataramanan R, Burckart GJ, Gray JA, Van Thiel DH, Sanghvi A, Rosenthal Th. J. Cyclosporine kinetics in healthy volunteers Journal of Clinical Pharmacology. 27: 243-248. PMID 3680581 DOI: 10.1002/J.1552-4604.1987.Tb02193.X |
0.369 |
|
| 1987 |
Burckart GJ, Ptachcinski RJ, Jones DH, Howrie DL, Venkataramanan R, Starzl TE. Impaired clearance of ceftizoxime and cefotaxime after orthotopic liver transplantation Antimicrobial Agents and Chemotherapy. 31: 323-324. PMID 3551835 DOI: 10.1128/Aac.31.2.323 |
0.374 |
|
| 1987 |
Zaghloul I, Ptachcinski RJ, Burckart GJ, Van Thiel D, Starzel Th. E, Venkataramanan R. Blood protein binding of cyclosporine in transplant patients Journal of Clinical Pharmacology. 27: 240-242. PMID 3316307 DOI: 10.1002/J.1552-4604.1987.Tb02192.X |
0.383 |
|
| 1986 |
Burckart GJ, Venkataramanan R, Ptachcinski RJ, Starzl TE, Gartner JC, Zitelli BJ, Malatack JJ, Shaw BW, Iwatsuki S, Van Thiel DH. Cyclosporine absorption following orthotopic liver transplantation Journal of Clinical Pharmacology. 26: 647-651. PMID 3540030 DOI: 10.1002/J.1552-4604.1986.Tb02966.X |
0.403 |
|
| 1986 |
Burckart GJ, Venkataramanan R, Ptachcinski RJ, Starzl TE, Griffith BP, Hakala TR, Rosenthal JT, Hardesty RL, Iwatsuki S, Brady J. Cyclosporine pharmacokinetic profiles in liver, heart, and kidney transplant patients as determined by high-performance liquid chromatography Transplantation Proceedings. 18: 129-136. PMID 3538565 |
0.303 |
|
| 1986 |
Venkataramanan R, Yang S, Burckart GJ, Ptachcinski RJ, Van Thiel DH, Starzl TE. Diurnal variation in cyclosporine kinetics Therapeutic Drug Monitoring. 8: 380-381. PMID 3529520 DOI: 10.1097/00007691-198609000-00027 |
0.416 |
|
| 1986 |
Ptachcinski RJ, Burckart GJ, Venkataramanan R. Cyclosporine concentration determinations for monitoring and pharmacokinetic studies Journal of Clinical Pharmacology. 26: 358-366. PMID 3517078 DOI: 10.1002/J.1552-4604.1986.Tb03538.X |
0.391 |
|
| 1986 |
Mehta MU, Venkataramanan R, Burckart GJ, Ptachcinski RJ, Yang SL, Gray JA, Van Thiel DH, Starzl TE. Antipyrine kinetics in liver disease and liver transplantation Clinical Pharmacology and Therapeutics. 39: 372-377. PMID 3514052 DOI: 10.1038/Clpt.1986.57 |
0.354 |
|
| 1986 |
Ptachcinski RJ, Venkataramanan R, Burckart GJ. Clinical Pharmacokinetics of Cyclosporin Clinical Pharmacokinetics. 11: 107-132. PMID 3514043 DOI: 10.2165/00003088-198611020-00002 |
0.457 |
|
| 1986 |
Venkataramanan R, Burckart GJ, Ptachcinski RJ. Cyclosporine pharmacokinetics in heart transplant patients Transplantation Proceedings. 18: 768-770. |
0.312 |
|
| 1985 |
Venkataramanan R, Ptachcinski RJ, Burckart GJ, Yang S, Starzl TE. Extraction ratio of cyclosporine in a liver transplant patient with organ rejection Journal of Pharmaceutical Sciences. 74: 901-902. PMID 3897511 DOI: 10.1002/Jps.2600740824 |
0.391 |
|
| 1985 |
Ptachcinski RJ, Venkataramanan R, Rosenthal JT, Burckart GJ, Taylor RJ, Hakala TR. Cyclosporine kinetics in renal transplantation Clinical Pharmacology and Therapeutics. 38: 296-300. PMID 3896612 DOI: 10.1038/Clpt.1985.174 |
0.354 |
|
| 1985 |
Ptachcinski RJ, Venkataramanan R, Rosentha JT, Burckart GJ, Taylor RJ, Hakala TR. The effect of food on cyclosporine absorption Transplantation. 40: 174-176. PMID 3895624 DOI: 10.1097/00007890-198508000-00013 |
0.306 |
|
| Show low-probability matches. |